Stratedigm Inc. and LK Bioscience announced a strategic agreement for the commercial distribution of Stratedigm’s analyzers in South Korea. LK BioScience has been distributing flow cytometry reagents, instrumentation, and other Biomedical related products to scientists and researchers in South Korea since 2005.
“LK BioScience’s extensive experience and strong management team made them the ideal candidate for distributing our products in South Korea. With over 35 years of experience in sales and marketing of flow cytometry products for companies such as BD Korea, LK Bioscience executives, Yu-sik Lim and Barbie Kim, bring the depth of knowledge required to grow our international presence while providing the same level of exemplary support our customers have grown to expect from Stratedigm.
We have been diligently searching for the best partners to represent our brand internationally and are excited about the expansion of our operations to South Korea, Singapore, China and Thailand,” noted Shervin Javadi, Stratedigm’s CEO.